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Objective: Little is known about which women are at greatest risk of adverse psychological 
after-effects following colposcopy. This study examined time trends in, and identified predictors 
of, anxiety and specific worries over 12 months. 
Methods: Women attending two hospital-based colposcopy clinics for abnormal cervical 
cytology were invited to complete psychosocial questionnaires at 4, 8 and 12 months following 
colposcopy. General anxiety and screening-specific worries (about cervical cancer, having sex 
and future fertility) were measured. Generalized estimating equations were used to assess 
associations between socio-demographic, lifestyle and clinical variables and risk of 
psychological outcomes. 
Results: Of 584 women initially recruited, 429, 343 and 303 completed questionnaires at 4, 8 
and 12 months, respectively. Screening-specific worries declined significantly over time but 
were still relatively high at 12 months: 23%, 39% and 18% for worries about cervical cancer, 
fertility and having sex, respectively.  Anxiety remained stable (20%) over time. Risks of 
cervical cancer worry and anxiety were both almost double in women without private health 
insurance (cervical cancer worry: OR=1.80, 95% CI 1.25-2.61; anxiety: OR=1.84, 95% CI 1.20-
2.84). Younger women (<40 years) had higher risk of fertility worries. Non-Irish women had 
higher risk of anxiety (OR=2.13, 95% CI 1.13-4.01).  
Conclusions: Screening-specific worries declined over time but anxiety remained stable. 
Notable proportions of women still reported adverse outcomes 12 months following colposcopy, 
with predictors varying between outcomes. Women in socio-demographically vulnerable groups 
were at greatest risk of adverse psychological outcomes. This information could inform 





Colposcopy can be a distressing experience for women and studies have shown that women have 
raised anxiety levels prior to, and during, the examination [1-4] Evidence is accruing that, for 
some women, colposcopy is also associated with adverse psychological effects afterwards [5, 6]; 
for example, a recent systematic review concluded that diagnosis of CIN and treatment (in which 
colposcopy plays an important role) is associated with negative psychological outcomes for 
women [7]. However, there are limitations to the current evidence-base in relation to post-
colposcopy psychological wellbeing. Firstly, although several studies have suggested that 
women with abnormal cytology test results have quite specific concerns - for example, about 
cervical cancer, future fertility and having sex [8-10] - few studies have quantified these worries 
following colposcopy. Instead, most studies have used measures of generalised distress [11-13]. 
Secondly, the temporal pattern of psychological after-effects of colposcopy is unclear. In a 
systematic review, we found that evidence on temporal trends of anxiety and distress was limited 
and inconsistent; and overall, very little is known about what happens to these screening-specific 
concerns over time following colposcopy [14].  
Thirdly, there are significant gaps in the current evidence-base on predictors of negative 
psychological outcomes following colposcopy [14]. From the limited data available, 
management and treatment factors do not appear to affect the risk of negative psychological 
consequences, although women with cervical intraepithelial neoplasia grade 2+ (CIN2+) may be 
at increased risk [5,15, 16]. Most studies considered a very limited range of potential predictors. 
Only one study, the UK TOMBOLA trial, has looked in detail at which subgroups of women are 
at higher risk. However, in this analysis, assessment of procedure-related distress took place at a 
short period of time (6 weeks) after women’s most recent procedure [6]. Moreover, most of the 
available studies conducted only univariate analyses, despite the fact that potential predictors are 
inter-related [14]. A more comprehensive understanding of the predictors of adverse 
psychological outcomes might help clinicians and other medical professionals identify “at-risk” 
women and provide appropriate psychological support. 
The current study aimed to address the gaps in this evidence-base by: (1) investigating the 
temporal patterns of general anxiety and specific worries following colposcopy and related 
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procedures (at 4, 8 and 12 months) and (2) identifying potential predictors of these adverse 
outcomes over this 12-month period.  
Methods 
Setting 
The study setting was Ireland, which has a mixed public-private healthcare system. 
Approximately 45% of the population have private health insurance [17] and approximately 40% 
are entitled to free health care services under the General Medical Services (GMS) Scheme, 
eligibility for which is based on (low) income and/or (older) age [18]. A national cervical cancer 
screening programme, CervicalCheck, was implemented in 2008, offering free cervical cytology 
tests and follow-up, if required, to women aged 25-60 years [19]. Women typically attend their 
family doctor’s practice for a cytology test. Women with two or more low-grade abnormal 
cervical cytology test results, or one high-grade result, are referred for hospital–based 
colposcopy in a clinic affiliated with the screening programme [19]. 
Participants 
Women who attended two large colposcopy clinics affiliated with CervicalCheck were recruited 
to the study between September 2010 and July 2011. Eligible women were those who had been 
referred to colposcopy on the basis of an abnormal cervical cytology test result; they were 
eligible irrespective of the management they received at their initial clinic appointment (i.e. 
colposcopy only, punch biopsies, loop excision, or another form of treatment) or subsequent 
follow-up. From hereonin, we use the term “colposcopy” for brevity to include colposcopy with 
or without related procedures and treatment. Women were ineligible if pregnant at the time of 
recruitment (i.e. at the initial colposcopy clinic appointment) or had previously had treatment for 
cervical abnormalities. At their clinic appointment, women were invited to take part in the study 
by research staff and were given a study information sheet. Those interested in participating 
signed consent forms and returned them to research staff. Ethical approval was obtained from the 
ethics committees of the Coombe Women and Infants University Hospital and the National 
Maternity Hospital, Dublin.  
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Assessment of psychological outcomes 
Consenting women were invited to complete a psychosocial questionnaire which was sent by 
post at 4, 8 and 12 months following their initial colposcopy appointment. The outcomes of 
interest for this analysis were 1) generalised anxiety and 2) specific worries about cervical 
cancer, future fertility and having sex. Anxiety was assessed by the Hospital Anxiety and 
Depression Scale (HADS) [20]. The HADS was originally designed to screen for clinically 
significant anxiety and depression in hospital outpatient clinics, but has subsequently been 
validated in community settings [21]. Questions on the HADS refer to the past week; women 
were invited to complete the full instrument but only the seven questions forming the anxiety 
subscale were considered in this analysis. Specific worries about cervical cancer, future fertility 
and having sex were assessed using three items from the Process Outcome Specific Measure 
(POSM), which was developed to assess issues of concern to women being followed-up for 
abnormal cervical cytology [9]. These three statements have six-level Likert response options 
ranging from ‘Strongly agree’ to’ Strongly disagree’ and refer to the period of the previous 
month. For example, the statement about cervical cancer is: “In the last month I have been 
worried that I may have cervical cancer”. The other two items have similar wording.  
Assessment of potential predictors of anxiety and specific worries 
Information on potential predictors of psychological outcomes was obtained from the first 
questionnaire, administered 4 months following the initial colposcopy appointment. This 
contained questions on socio-demographic characteristics and lifestyle behaviours, including 
age, education level, private health insurance and smoking status. Social support was assessed 
using one item (“About how many close friends and close relatives do you have (people you feel 
at ease with and can talk to about what is on your mind)?”), which was adapted from the Oslo-3 
social support scale [22]. Women’s satisfaction with life and general health care were assessed 
using items adapted from McCaffery et al. [23]. Information on clinical variables at, and 
following, the initial colposcopy appointment was obtained from hospital clinic records. Data 
extracted from clinic records were: colposcopy referral cytology, initial colposcopic impression, 
initial management received and initial histology results. Table 1 lists all the potential socio-
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demographic and lifestyle predictors, and Table 2 the potential clinical predictors, of anxiety and 
specific worries available for analysis  
Statistical analyses 
Binary psychological outcome variables were created classifying women’s surveys responses 
according to whether or not they were anxious, worried about cervical cancer, worried about 
future fertility and worried about having sex. Outcome variables were created for each 
assessment time point. Presence of clinically significant anxiety was defined as a HADS anxiety 
subscale score of ≥11 [20]. Responses to the questions on worries about cancer, fertility and sex 
were collapsed to produce a dichotomous variable (agree/disagree corresponding to 
worried/unworried) for each outcome.  
Generalised Estimating Equations (GEE) were used to assess associations between socio-
demographic, lifestyle, clinical variables and risk of each of the four psychological outcomes. 
GEE methods take into account within-subject correlations in longitudinal data and produce 
robust error estimates. They do not require all subjects to have completed the survey at every 
time point for inclusion; instead they allow for the inclusion of all surveys completed by each 
woman. A model was built for each of the four psychological outcomes. QIC (quasi-likelihood 
under the independence model criterion) statistics were used to select the best correlation 
structure (from among the four possible structures) for each model, with the model structure with 
the lowest QIC being chosen.   
Univariate logistic regression was used initially to determine which potential predictors should 
be considered as candidate variables for inclusion in the multivariate models. Variables that were 
significant at the 5% level in the univariate analysis were included in the initial multivariate 
analysis and Wald tests used to determine which remained significant, given the presence of 
other independent variables. The final models only included variables that remained significant, 
with the exception of the time-point variable (i.e. 4, 8 or 12 months) which was included in all 






Characteristics of participants 
Of 584 women who agreed to take part in the study: 429 (73%) completed questionnaires at 4 
months following their initial colposcopy; 343 (59%) completed questionnaires at 8 months; and 
303 (52%) completed questionnaires at 12 months. Women’s socio-demographic, attitudinal and 
lifestyle characteristics at the 4-month time-point are summarised in Table 1. Women’s clinical 
characteristics at the 4-month time-point are summarised in Table 2.   
Prevalence and temporal trends of anxiety and specific worries post-colposcopy 
Supplementary Figure 1 shows the prevalence of anxiety and worries about cervical cancer, 
future fertility and having sex at 4, 8 and 12 months following the initial colposcopy. Over the 
entire follow-up period, the prevalence of anxiety remained stable at around 20%, but specific 
worries declined significantly over time (see Supplementary Figure 1). The prevalence of 
worries about cervical cancer at 4, 8 and 12 months was 36%, 28% and 23%, respectively. The 
prevalence of worries about future fertility was 56%, 47% and 39%. In terms of having sex, 29% 
were worried at 4 months, 20% at 8 months and 18% at 12 months. These patterns persisted after 
adjustment for (other) significant predictors (Tables 3, 4, 5 and Supplementary table 2).   
Predictors of anxiety over 12 months post-colposcopy 
The univariate analyses of associations between socio-demographic, attitudinal, lifestyle and 
clinical variables and anxiety are shown in Supplementary table 1.  In multivariate analysis, the 
following variables were significantly associated with increased risk of anxiety: nationality, 
private health insurance, history of depression and satisfaction with life (Table 3). The odds of 
anxiety were more than twice as high in women who were non-Irish compared to Irish women 
(multivariate OR=2.13, 95% CI 1.13 – 4.01). The likelihood of anxiety was also more than twice 
as high in women who had a history of depression compared to those who did not (OR=2.33, 
95% CI 1.51 – 3.60). Having no private health insurance was associated with significantly higher 
likelihood of anxiety (OR=1.84, 95% CI 1.20 – 2.84). A higher satisfaction with life was related 
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to significantly lower likelihood of anxiety: with every 1 point increase in life satisfaction score, 
the odds of anxiety were reduced by one-third (OR=0.67, 95% CI 0.59 – 0.76). 
Predictors of worries about cervical cancer over 12 months post-colposcopy 
Univariate results are shown in Supplementary table 1. In addition to time point, private health 
insurance, smoking status, satisfaction with life and perceived severity of colposcopy 
examination significantly predicted worries about cervical cancer in the multivariate model 
(Table 4). Compared with current smokers, the odds of worries about cervical cancer were non-
significantly lower in those who had never smoked (OR=0.74, 95% CI 0.48 – 1.15) and 
significantly lower in those who were past smokers (OR=0.52, 95% CI 0.33 – 0.80). The odds of 
worries about cervical cancer were raised by approximately 80% in those who had no private 
health insurance (multivariate OR=1.80, 95% CI 1.25 – 2.61). A higher satisfaction with life was 
related to significantly lower likelihood of worries about cervical cancer: with every 1 point 
increase in life satisfaction, the odds of worries about cervical cancer were reduced by 12% 
(OR=0.88, 95% CI 0.80 – 0.96). Perceived severity of the colposcopy examination was 
positively associated with worries about cervical cancer: with every 1 point increase in perceived 
severity of the colposcopy examination the odds of anxiety were increased by 84%. (OR=1.84, 
95% CI 1.45 – 2.33). 
Predictors of worries about future fertility over 12 months post-colposcopy 
Univariate results are shown in Supplementary table 1. In multivariate analysis, the following 
significantly predicted worries about future fertility: age, pregnancy status and smoking status 
(Table 5). The odds of worries about future fertility were 82% lower in women over 40 years 
(OR=0.18, 95% CI 0.06 – 0.51) compared to women younger than 30 years. Women who were 
not pregnant had a significantly higher likelihood of worries about future fertility than women 
who were pregnant at the time of 4 month questionnaire (OR=4.17, 95% CI 1.61 – 10.81). 
Compared to current smokers, the odds of worries about future fertility were halved in those who 
had never smoked (OR=0.50, 95% CI 0.30 – 0.83) and in past smokers (multivariate OR=0.49, 
95% CI 0.28 – 0.86); both risk estimates were significantly different from unity.  
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Predictors of worries about having sex over 12 months post-colposcopy 
Univariate results are shown in Supplementary table 1. In multivariate analysis, the following 
were significant predictors of worries about having sex: age, satisfaction with life, perceived 
severity of the colposcopy examination and initial colposcopy histology result (Supplementary 
table 2). The odds of worries about having sex were almost 40% lower in women aged 30–40 
years (OR=0.62, 95% CI 0.40 – 0.96), and almost 50% lower in women over 40 years (OR=0.52, 
95% CI 0.33 – 0.82), compared to women younger than 30 years. Women who reported higher 
satisfaction with life had significantly lower risk of worries about having sex (OR=0.83, 95% CI 
0.75 – 0.92). Higher perceived severity of the colposcopy examination was positively associated 
with worries about having sex (OR=1.57, 95% CI 1.22 – 2.03). Compared to women with 
CIN2+, the odds of worries about having sex was halved in women with CIN 1 (OR=0.50, 95% 
CI 0.30 – 0.84) and 75% lower in women without CIN (OR=0.26, 95% CI 0.14 – 0.47); both risk 




Using a powerful longitudinal design, and multivariate analyses, this study examined temporal 
trends in anxiety and specific worries about fertility, cancer and sex, over 12 months post-
colposcopy. Anxiety remained stable while worries declined, but all four outcomes still affected 
notable proportions of women at 12 months post-colposcopy. The study also identified socio-
demographic, attitudinal, lifestyle, and clinical factors that were significantly associated with risk 
of adverse psychological outcomes post-colposcopy.  
Prevalence and temporal trends of anxiety and specific worries 
The prevalence of anxiety post-colposcopy in our study was stable over time and similar to 
levels reported in two UK studies that assessed anxiety in women post-colposcopy using the 
HADS [24, 25]. However, it was higher than reported in the UK TOMBOLA trial [6] which 
followed women from approximately 6 weeks (8% had anxiety) to 30 months post-colposcopy 
(14% had anxiety). In that trial, all women had low-grade cytology and many had only a single 
test showing borderline nuclear abnormalities while in our study women with two low-grade or 
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one high-grade test results were eligible. This – and the fact that the two studies assessed women 
at different time-points - may explain the difference in prevalence of anxiety.  
Data on specific post-colposcopy concerns (i.e. worries about cervical cancer, future fertility and 
having sex) is limited. A Swedish study [3], found the prevalence of cancer worries at 6 and 24 
months post-colposcopy was 26% and 30%, respectively, compared to 36% and 28% at 4 and 8 
months in our study. Prevalence of worries about future fertility was considerably higher in our 
study (4 months: 56%; 8 months: 47%; 12 months: 39%) than in the Swedish study (6 months: 
31%; 12 months: 20%). This might be explained by the higher proportion of women aged 30 and 
older in our study (64% compared to 33% in [3]). Although there is a lack of empirical evidence 
about fertility concerns in the general population, it seems likely that these would be most 
prevalent among women in their 30s, as their fertility begins to decline.  These findings suggest 
colposcopy could stimulate more concerns about future fertility among women who have a 
shorter time window in which to conceive (i.e. women in their 30s compared to 20s).  
Prior to our study, limited data were available on prevalence of anxiety and specific worries 
following colposcopy. In particular, very limited data were available on temporal trends in 
anxiety and specific worries. Only one study, referred to earlier, assessed worries about future 
infertility and cancer at two-timepoints after colposcopy (~6 and 24 months) [3]. Although a 
number of studies have evaluated sexual/psychosexual issues post-colposcopy [14], as far as we 
are aware, our study is the first to investigate temporal trends in worries about having sex. 
Moreover, our study provides valuable data on temporal patterns of anxiety (which remained 
stable over the 12 month follow-up period) and worries about cervical cancer and future fertility 
following colposcopy.  While we have shown falling worries over time, the prevalence of 
specific concerns at 12 months was still relatively high. These findings suggest, firstly, that 
women may need to be monitored longer-term for post-colposcopy worries and, secondly, that a 
psycho-educational intervention aimed at alleviating these longer-term concerns is required.  
Predictors of anxiety and worries 
The risks of worries about cervical cancer and anxiety were almost double in women who did not 
have private health insurance. Not having private health insurance is a marker of lower socio-
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economic status in Ireland and, in the population as a whole, various markers of lower socio-
economic status are associated with higher rates of mental health problems [26]; this association 
could explain our finding. Alternatively, it is worth noting that, in Ireland, those who have 
private health insurance associate it with advantages such as reassurance about timely access to 
healthcare and treatment [27]. Therefore, although CervicalCheck provides screening free at the 
point of delivery, it is possible that women with no private health insurance are more worried 
about getting cervical cancer because of concerns about access to cancer treatment services in the 
public system. Identifying women without private health insurance and better supporting them in 
relation to their worries during their follow-up might provide a route to alleviate some of the 
post-colposcopy psychological burden. 
Previous studies have shown that younger women are more worried about possible consequences 
of abnormal cytology results on future fertility than older women [6, 10, 28]. We have extended 
these findings by showing that being younger (<40 years) is a significant predictor of worries 
about future fertility following colposcopy. Our findings suggest that younger women 
undergoing colposcopy may benefit from more detailed information on the actual risks of 
colposcopy/related procedures impacting on their fertility performance and obstetric outcomes. 
Evidence suggests that colposcopy alone does not impact on time to conceive [29] and that CIN 
treatment is associated with only a very small increased risk of preterm delivery [30]. This 
evidence could be communicated to women to help reassure and alleviate fertility concerns. 
Women in our study who were non-Irish nationals were at increased risk of anxiety following 
colposcopy compared to Irish women. This echoes the large disparities observed in different 
healthcare settings in cervical screening uptake by ethnic backgrounds (see, for example, [31, 
32]).  Non-Irish women may not have English as their first language and may therefore find it 
difficult to understand information about colposcopy which, in turn, could increase the likelihood 
of anxiety following colposcopy. While the Irish cervical screening programme has produced 
information leaflets in 11 languages, these do not include information on women’s follow-up. In 
addition, recent immigrants to Ireland may find it difficult to navigate the complex health 
system. Women from different cultural backgrounds hold different beliefs about cervical 
cytology tests [33]; they may also hold different beliefs about colposcopy. Development of more 
culturally relevant cervical screening (including follow-up) information leaflets for non-Irish 
12 
 
women is needed. More support generally, and assistance with patient navigation, for non-Irish 
women, could help reduce the risk of anxiety in these women following colposcopy. 
Perceiving the colposcopy examination as serious/very serious was a significant predictor of 
worries about cervical cancer and having sex following colposcopy. Women’s understanding of 
the purpose of colposcopy is poor [34, 35] and, in qualitative research, we found that women 
want more detailed information on what a colposcopy entails [36]. Providing more specific 
information, and eliciting and, where appropriate changing, women’s perceptions of the 
colposcopy examination prior to undergoing the procedure, could help to alleviate subsequent 
worries.  
Considering the findings overall, two striking observations emerge. Firstly, different predictors 
are somewhat distinctly associated with different screening-specific worries following 
colposcopy. For example not having private health insurance was a significant predictor of 
worries about cervical cancer and being younger in age (<40 years) was a significant predictor of 
worries about future fertility. Secondly, notwithstanding this, women who could be perceived as 
socio-demographically ‘vulnerable’ or disadvantaged were at higher risk of poor psychological 
outcomes. Low socio-economic status environments may stimulate disproportionate levels of 
negative emotions such as worry which in turn mediate the relationship between socio-economic 
status and health [37]. Appropriate psycho-educational interventions targeting these ‘vulnerable’ 
women could benefit their psychological wellbeing following colposcopy. For example, it may 
be important to reassure women with no private health insurance about cervical cancer risk. 
Given that women who have abnormal cytology often require at least one colposcopy, treatment, 
and in some cases, intensive follow-up, it is the responsibility of cervical screening programmes 
to identify these vulnerable women and provide them with the necessary support throughout their 
follow-up. 
Strengths and limitations 
Our study examined, for the first time in a comprehensive way, socio-demographic, attitudinal, 
lifestyle and clinical predictors of adverse psychological after-effects of colposcopy. We used 
GEE, a powerful and robust analysis method which makes use of all data points available, to 
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examine the temporal trends and potential predictors of post-colposcopy distress. With the 
exception of the UK TOMBOLA trial [38], this study is the largest to have investigated adverse 
psychological after-effects of colposcopy and related interventions. Although women were 
recruited from only two colposcopy clinics, both are affiliated with CervicalCheck and are 
located in hospitals with socio-economically diverse catchment areas. While there is no reason to 
assume that women who consented to the study are not typical of women attending colposcopy 
clinics throughout Ireland, we cannot be certain of this. Other limitations are: the unknown 
participation rate (i.e. percentage of women attending colposcopy who consented to receive 
questionnaires),  the possibility that questionnaire responders and non-responders differed in 
terms of frequency of anxiety and specific worries, and the fact that we did not have information 
on management women received for CIN2+ after the initial colposcopic management and 
associated procedures.   
 
Conclusions 
Our study provides insight into the temporal trends in adverse psychological outcomes over a 12 
month period following colposcopy; anxiety remained stable over time while specific worries 
declined. In addition, we have, for the first time, shown that different predictors are differentially 
associated with different screening-specific worries post-colposcopy and, in general, that women 
who could be perceived as socio-demographically ‘vulnerable’ or potentially disadvantaged are 
at increased risk. These findings may inform the development of support services and/or 
interventions to minimise risk of adverse psychological effects post-colposcopy.  
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 < 30 years 153 36.0 
 30 – 40 years 146 34.4 
 > 40 years 126 29.6 
 Not stated 4  
Highest level of education completed  
 Third level (e.g. college, university) 286 67.5 
 Primary/secondary 138 32.5 
 Not stated 5  
Employment status  
 Employed (working for an employer or self-employed) 306 71.7 
 Other*  121 28.3 
 Not stated 2  
Marital status  
 Married/cohabiting 199 46.7 
 Divorced/separated/widowed 36 8.5 
 Single 191 44.8 
 Not stated 3  
Nationality  
 Irish 386 90.8 
 Other 39 9.2 
 Not stated 4  
Have children  
 Yes 215 50.6 
 No 210 49.4 
 Not stated 4  
Currently pregnant  
 Yes***** 17 4.0 
 No 410 96.0 
 Not stated 2  
Private health insurance  
 Yes 207 48.4 
 No 221 51.6 
 Not stated 1  
Smoking status  
 Current smoker  140 32.8 
 Past smoker 134 31.4 
 Never smoked 153 35.8 
 Not stated 2  
History of depression**  
 Yes 123 28.9 
 No 303 71.1 
 Not stated 3  
Social support: No. of close friends and relatives  
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 Mean 7.4 (5.7) - 
Satisfaction with life  
 Mean (SD) satisfaction with life 7.3 (1.8)*** - 
Satisfaction with healthcare  
 Mean satisfaction with healthcare 5.0 (1.1)**** - 
Ever had an abnormal cervical cytology test result  
 Yes 247 58.3 
 No 177 41.7 
 Not stated 5  
Ever had a colposcopy examination  
 Yes 89 20.8 
 No 339 79.2 
 Not stated 1  
Perceived severity of colposcopy exam  
 Not at all serious 25 5.9 
 Slightly serious 210 49.2 
 Serious 149 34.9 
 Very serious 43 10.1 
 Not stated 2  
*Unemployed, retired from employment, unable to work, looking after family/home or student; **Self-reported 
depression; ***mean is from possible Likert score of 1-10; ****mean is from possible Likert score of 1-7; 
*****women who were pregnant at the time of the 4-month questionnaire but not pregnant at recruitment (the initial 








Referral cytology test result  
 Low grade (borderline, mild ) 329 76.7 
 High grade (moderate, severe ) 95 22.1 
 Not available 5 1.2 
Colposcopic impression  
 Normal 114 26.6 
 Abnormal 293 68.3 
 Unsatisfactory 8 1.9 
 Not available 14 3.3 
Initial management received*  
 Colposcopy only 110 25.8 
 Colposcopy plus punch biopsies** 241 56.4 
 Colposcopy plus LLETZ† 76 17.8 
 Not available 2  
Histology result at/following initial colposcopy  
 No CIN  65 15.2 
 CIN 1 90 21.0 
 CIN 2+ 145 33.8 
 Result unavailable/colposcopy unsatisfactory 129 30.1 
*Data from initial colposcopy appointment only and not subsequent colposcopy clinic visits;**Women had 1 or 
more biopsies taken with their colposcopy, with further procedures dependant on biopsy 
findings;†Women had colposcopy and were managed by immediate treatment (LLETZ; Large Loop Excision of the 




Table 3. Multivariate analysis of predictors of anxiety over 12 months post-colposcopy: odds ratios  
(OR), 95% confidence intervals (CI) and Wald test p values 
    
Variable* Multivariate 
OR 
95% CI Wald test 
   
Timepoint post-colposcopy   
4 months  1 -  
8 months  1.17 0.88-1.55  
12 months  1.01 0.76-1.34 0.505 
Nationality    
Irish 1 -  
Other 2.13 1.13-4.01 0.020 
Private health insurance   
Yes 1 -  
No 1.84 1.20-2.84 0.006 
History of depression†   
No 1 -  
Yes 2.33 1.51-3.60 <0.001 
Satisfaction with life   
Per unit increasea 0.67 0.59-0.76 <0.001 
*Measured at 4 months post-colposcopy. No. of observations = 996 across 416 individuals; †self-reported 
depression measured on the 4 month questionnaire. alower score indicates lower satisfaction with life,  




Table 4. Multivariate analysis of predictors of worries about cervical cancer over 12 months  
post-colposcopy: odds ratios (OR), 95% confidence intervals (CI) and Wald test p values 
    
Variable* Multivariate 
OR 
95% CI Wald test 
    
Timepoint post-colposcopy    
4 months 1 -  
8 months 0.63 0.47-0.83  
12 months 0.57 0.41-0.78 <0.0001 
Private health insurance    
Yes 1 - - 
No 1.80 1.25-2.61 0.002 
Smoking status    
Current smoker 1 -  
Past smoker 0.52 0.33-0.80  
Never smoked 0.74 0.48-1.15 0.012 
Satisfaction with life    
Per unit increasea  0.88 0.80-0.96 0.006 
Perceived severity of colposcopy exam    
Per unit increaseb 1.84 1.45-2.33 <0.001 
*Measured at 4 months post-colposcopy. No. of observations =1007 across 419 individuals; aLikert  
scale range 1-10; Completely satisfied =10; bhigher score indicates higher perceived severity, Likert  




Table 5. Multivariate analysis of predictors of worries about future fertility over 12 months  
post-colposcopy: odds ratios (OR), 95% confidence intervals (CI) and Wald test p values 
   
Variable* Multivariate 
OR 
95% CI Wald test 
    
Timepoint post-colposcopy    
4 months 1 -  
8 months 0.63 0.45-0.88  
12 months 0.51 0.36-0.73 0.001 
Age    
< 30 years 1 -  
30 – 40 years 1.26 0.81-1.96  
> 40 years 0.18 0.06-0.51 0.002 
Currently pregnant**    
Yes 1 -  
No 4.17 1.61-10.81 0.003 
Smoking status    
Current smoker 1 -  
Past smoker 0.49 0.28-0.86  
Never smoked 0.50 0.30-0.83 0.012 
*Measured at 4 months post-colposcopy. No. of observations =599 across 301 individuals;  
Correlation structure = Independent; **at the time of the 4 month questionnaire. 
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Supplementary Table 1. Results of univariate analyses for each of the 4 outcomes: odds ratios (OR), 95% confidence intervals (CI) and p values from Chi Square tests 
 Anxietya Worried about cervical 
cancerb 
Worried about  
future fertilityc 
Worried about having sexd 
Variable       
 OR 95% CI OR 95% CI OR  95% CI OR 95% CI 
Time-point        
4 months 1 - 1 - 1 - 1 - 
8 months 1.14 0.90-1.44 0.67 0.53-0.86 0.67 0.49-0.92 0.59 0.43-0.79 
12 months 1.01 0.80-1.28 0.57 0.43-0.75 0.49 0.35-0.68 0.54 0.40-0.75 
 p=0.485 p < 0.001 p < 0.001 p<0.001 
Socio-demographic, attitudinal and lifestyle variables     
Nationality      
Irish 1 - 1 - 1 - 1 - 
Other 2.05 1.11-3.80 1.52 0.86-2.67 1.29 0.61-2.70 1.40 0.74-2.65 
 p=0.022 p = 0.149 p=0.502 p=0.295 
Highest level of education 
completed 
     
Third level 1 - 1 - 1 - 1 - 
Primary/Secondary level 1.25 0.81-1.91 1.55 1.10-2.19 0.98 0.59-1.65 1.22 0.84-1.78 
 p=0.312 p=0.013 p=0.952 p=0.297 
Employment status      
Employed 1 - 1 - 1 - 1 - 
Other 1.54 1.00-2.36 1.56 1.08-2.25 0.90 0.54-1.52 1.81 1.24-2.64 
 p=0.049 p = 0.017 p=0.704 p=0.002 
Marital status      
Married/living with partner 1 - 1 - 1 - 1 - 
Single 0.93 0.61-1.40 1.26 0.89-1.79 1.19 0.78-1.82 1.13 0.78-1.63 
Separated/Widowed/Divorced 1.09 0.51-2.35 0.71 0.37-1.36 0.21 0.07-0.62 1.22 0.61-2.45 
 p=0.883 p = 0.144 p=0.006 p=0.759 
Age      
< 30 years 1 - 1 - 1 - 1 - 
30 - 40 years 0.92 0.58-1.44 0.79 0.53-1.18 1.03 0.66-1.60 0.69 0.45-1.04 
> 40 years 0.57 0.34-0.97 0.72 0.47-1.09 0.17 0.07-0.46 0.53 0.34-0.83 
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 p=0.098 p = 0.258 p=0.001 p=0.018 
Have children      
Yes 1 - 1 - 1 - 1 - 
No 0.88 0.59-1.32 0.67 0.48-0.94 1.82 1.17-2.83 0.99 0.70-1.42 
 p=0.550 p=0.019 p=0.008 p=0.975 
Currently pregnant      
Yes 1 - 1 - 1 - 1 - 
No 1.67 0.52-5.40 2.51 0.78-8.09 3.62 1.49-8.83 0.61 0.27-1.41 
 p = 0.391 p = 0.122 p=0.005 p=0.249 
Medical card      
Full medical card 1 - 1 - 1 - 1 - 
GP card 1.30 0.50-3.41 0.82 0.32-2.11 0.63 0.18-2.17 0.91 0.39-2.14 
None 0.51 0.32-0.80 0.59 0.41-0.87 0.76 0.45-1.28 0.55 0.37-0.82 
 p=0.004 p=0.025 p=0.541 p=0.010 
Private health insurance      
Yes 1 - 1 - 1 - 1 - 
No 1.83 1.22-2.75 2.16 1.54-3.05 1.18 0.78-1.77 1.67 1.16-2.39 
 p=0.003 p < 0.001 p=0.432 p=0.006 
Smoking status      
Current smoker 1 - 1 - 1 - 1 - 
Past smoker 0.58 0.36-0.94 0.38 0.25-0.58 0.59 0.35-1.01 0.78 0.50-1.20 
Never smoked 0.48 0.30-0.77 0.54 0.36-0.81 0.54 0.33-0.87 0.80 0.52-1.24 
 p = 0.006 p <0.001 p=0.030 p=0.460 
History of depression      
No 1 - 1 - 1 - 1 - 
Yes 3.61 2.38-5.46 1.55 1.07-2.24 1.40 0.89-2.19 1.31 0.89-1.93 
 p < 0.001 p = 0.020 p=0.141 p=0.166 
Satisfaction with life      
Per unit increase*  0.66 0.59-0.74 0.88 0.80-0.97 0.91 0.80-1.03 0.86 0.78-0.95 
 p < 0.001 p = 0.008 p=0.135 p=0.004 
Satisfaction with healthcare      
Per unit increase**  0.73 0.61-0.86 0.86 0.74-1.00 0.83 0.68-1.03 0.96 0.81-1.14 
 p < 0.001 p=0.047 p=0.085 p=0.663 
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Perceived severity of colposcopy 
exam 
     
Per unit increase***  1.28 0.97-1.68 1.85 1.48-2.32 1.18 0.90-1.53 1.73 1.35-2.20 
 p = 0.083 p<0.001 p=0.228 p<0.001 
Social support: No. of close friends 
and relatives 
     
Per unit increase 0.96 0.92-1.00 0.97 0.92-1.01 0.98 0.95-1.02 0.98 0.94-1.02 
 p = 0.069 p=0.149 p=0.296 p=0.299 
Ever had an abnormal cytology 
test result**** 
     
Yes 1 - 1 - 1 - 1 - 
No 1.07 0.71-1.60 1.39 0.99-1.96 1.25 0.82-1.89 1.24 0.87-1.78 
 p = 0.748 p=0.054 p=0.298 p=0.238 
Ever had a colposcopy†      
Yes 1 - 1 - 1 - 1 - 
No 0.74 0.46-1.18 0.93 0.61-1.42 0.87 0.51-1.48 0.96 0.61-1.52 
 p = 0.204 p=0.735 p=0.609 p=0.874 
Clinical variables     
Referral cytology test result      
Low grade(borderline, mild) 1 - 1 - 1 - 1 - 
High grade (moderate, severe) 1.22 0.77-1.92 1.44 0.98-2.12 0.84 0.48-1.47 1.57 1.05-2.33 
Not available         
 p = 0.394 p=0.062 p=0.548 p=0.027 
Colposcopic impression      
Normal 1 - 1 - 1 - 1 - 
Abnormal 1.14 0.73-1.77 1.75 1.16-2.63 1.39 0.89-2.17 1.74 1.13-2.69 
Unsatisfactory 0.74 0.13-4.07 1.40 0.54-3.60 0.32 0.04-2.54 0.45 0.11-1.75 
Not available 1.70 0.60-4.80 1.20 0.43-3.38 1.30 0.25-6.72 1.44 0.41-5.07 
 p = 0.723 p=0.058 p=0.286 p=0.021 
Initial management received‡      
Colposcopy plus punch biopsies 1 - 1 - 1 - 1 - 
Colposcopy only 0.95 0.60-1.49 0.94 0.62-1.43 0.93 0.58-1.47 0.73 0.47-1.13 
Colposcopy plus LLETZ 1.31 0.76-2.27 1.65 1.08-2.52 1.00 0.53-1.88 1.38 0.87-2.19 
 p=0.528 p=0.041 p=0.946 p=0.063 
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Initial colposcopy histology result      
CIN2+ 1 - 1 - 1 - 1 - 
CIN 1 1.04 0.60-1.81 0.53 0.33-0.85 0.84 0.48-1.49 0.44 0.26-0.73 
No CIN 0.79 0.42-1.49 0.41 0.24-0.69 0.36 0.18-0.75 0.24 0.13-0.45 
Result unavailable/colposcopy 
unsatisfactory 
0.80 0.49-1.31 0.52 0.34-0.79 0.71 0.44-1.16 0.41 0.27-0.64 
 p = 0.696 p = 0.001 p=0.050 p<0.001 
aCorrelation structure for anxiety =Unstructured. bCorrelation structure for worried about cervical cancer=Exchangeable. cCorrelation structure for worried about future 
fertility=Independent. dCorrelation structure for worried about having sex=Exchangeable. 
*range on Likert scale 1 - 10; Completely satisfied = 10. **range on Likert scale 1 - 7; Completely satisfied = 7. ***range on Likert scale 1 - 4; Very serious = 4. ****prior to taking 
part in the study. †prior to taking part in the study.‡ Data from initial colposcopy appointment only and not subsequent colposcopy clinic visits. 
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Supplementary Table 2. Multivariate analysis of predictors of worries about having sex over  
12 months post-colposcopy: odds ratios (OR), 95% confidence intervals (CI) and Wald test p values 
    
Variable* Multivariate 
OR 
95% CI Wald test 
    
Timepoint post-colposcopy    
4 months 1 -  
8 months 0.53 0.37-0.75  
12 months 0.57 0.39-0.83 0.001 
Age    
< 30 years 1 -  
30 – 40 years 0.62 0.40-0.96  
> 40 years 0.52 0.33-0.82 0.012 
Satisfaction with life    
Per unit increasea 0.83 0.75-0.92 <0.001 
Perceived severity of colposcopy exam    
Per unit increaseb 1.57 1.22-2.03 0.001 
Initial colposcopy histology result    
CIN2+ 1 -  
CIN1 0.50 0.30-0.84  
No CIN 0.26 0.14-0.47  
Result unavailable/colposcopy unsatisfactory 0.43 0.27-0.69 <0.001 
*Measured at 4 months post-colposcopy. No. of observations =996 across 415 individuals;  
Correlation structure = Exchangeable; aLikert scale range 1-10; Completely satisfied =10; bhigher score 



























4 months 8 months 12 months
Anxiety Cervical cancer Fertility Sex
